Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/885074/000143774919002620/aghc20181231_10q.htm
SEC Filings
AGHC Annual Reports
AGHC Quarterly Reports
AGHC Corporate News
Other Events November 2019
Financial Exhibit
New Agreement
Unregistered Sales October 2019
Unregistered Sales March 2019
Interim Review January 2019
Vote of Security Holders January 2019
Other Events December 2018
Event for Officers
Vote of Security Holders December 2018
Event for Officers
Other Events October 2018
Event for Officers September 2018
Financial Exhibit
New Agreement
New Financial Obligation
Unregistered Sales July 2018
Other Events
November 2019
Financial Exhibit
New Agreement
Unregistered Sales
New Agreement
Unregistered Sales
October 2019
Unregistered Sales
March 2019
Interim Review
January 2019
Vote of Security Holders
January 2019
Other Events
December 2018
Event for Officers
Vote of Security Holders
Vote of Security Holders
December 2018
Event for Officers
Other Events
Other Events
October 2018
Event for Officers
September 2018
Financial Exhibit
New Agreement
New Financial Obligation
Unregistered Sales
New Agreement
New Financial Obligation
Unregistered Sales
July 2018
Last10K.com | 10-Q Quarterly Report Thu Feb 14 2019
Document And Entity Information - shares | 6 Months Ended | |
|---|---|---|
Dec. 31, 2018 | Jan. 21, 2019 | |
| Document Information [Line Items] | ||
| Entity Registrant Name | Aeon Global Health Corp. | |
| Entity Central Index Key | 0000885074 | |
| Trading Symbol | aghc | |
| Current Fiscal Year End Date | --06-30 | |
| Entity Filer Category | Non-accelerated Filer | |
| Entity Current Reporting Status | Yes | |
| Entity Emerging Growth Company | false | |
| Entity Small Business | true | |
| Entity Common Stock, Shares Outstanding (in shares) | 7,415,064 | |
| Document Type | 10-Q | |
| Document Period End Date | Dec. 31, 2018 | |
| Document Fiscal Year Focus | 2019 | |
| Document Fiscal Period Focus | Q2 | |
| Amendment Flag | false |
View differences made from one quarter to another to evaluate Aeon Global Health Corp.'s financial trajectory
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Aeon Global Health Corp..
Assess how Aeon Global Health Corp.'s management team is paid from their Annual Proxy
Aeon Global Health Corp.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:
- Voting Procedures
- Board Members
- Executive Team
- Salaries, Bonuses, Perks
- Peers / Competitors
SEC Filing Tools
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Document And Entity Information
Condensed Consolidated Balance Sheets (Current Period Unaudited)
Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals)
Condensed Consolidated Statements Of Cash Flows (Unaudited)
Condensed Consolidated Statements Of Operations (Unaudited)
Condensed Consolidated Statements Of Shareholders' Equity (Unaudited)
Note 1 - Description Of Business, Reverse Merger And Liquidity
Note 1 - Description Of Business, Reverse Merger And Liquidity (Details Textual)
Note 10 - Fair Value Measurements And Other Financial Instruments
Note 10 - Fair Value Measurements And Other Financial Instruments (Details Textual)
Note 10 - Fair Value Measurements And Other Financial Instruments (Tables)
Note 10 - Fair Value Measurements And Other Financial Instruments - Derivative Liabilities (Details)
Note 10 - Fair Value Measurements And Other Financial Instruments - Summary In Changes In Fair Value (Details)
Note 10 - Fair Value Measurements And Other Financial Instruments - Valuation Techniques (Details)
Note 11 - Commitments And Contingencies
Note 11 - Commitments And Contingencies (Details Textual)
Note 12 - Related Party Transactions
Note 12 - Related Party Transactions (Details Textual)
Note 13 - Segment Information
Note 13 - Segment Information (Details Textual)
Note 13 - Segment Information (Tables)
Note 13 - Segment Information - Selected Financial Information (Details)
Note 2 - Summary Of Significant Accounting Policies
Note 2 - Summary Of Significant Accounting Policies (Details Textual)
Note 3 - Revenue Recognition
Note 3 - Revenue Recognition (Details Textual)
Note 3 - Revenue Recognition (Tables)
Note 3 - Revenue Recognition - Revenues By Type Of Customers (Details)
Note 4 - Inventory
Note 4 - Inventory (Tables)
Note 4 - Inventory - Inventory (Details)
Note 5 - Income Taxes
Note 5 - Income Taxes (Details Textual)
Note 6 - Related Party Notes Payable
Note 6 - Related Party Notes Payable (Details Textual)
Note 6 - Related Party Notes Payable (Tables)
Note 6 - Related Party Notes Payable - Related Party Notes Payable (Details)
Note 7 - Equity
Note 7 - Equity (Details Textual)
Note 7 - Equity (Tables)
Note 7 - Equity - Earnings Per Share (Details)
Note 7 - Equity - Warrant Activity (Details)
Note 8 - Share-Based Compensation
Note 8 - Share-Based Compensation (Details Textual)
Note 8 - Share-Based Compensation (Tables)
Note 8 - Share-Based Compensation - Restricted Stock Unit Activity (Details)
Note 8 - Share-Based Compensation - Stock Option Activity (Details)
Note 9 - Earn-Out Stock Compensation Plan
Note 9 - Earn-Out Stock Compensation Plan (Details Textual)
Significant Accounting Policies (Policies)
Material Contracts, Statements, Certifications & more
Aeon Global Health Corp. provided additional information to their SEC Filing as exhibits
Ticker: AGHC
CIK: 885074
Form Type: 10-Q Quarterly Report
Accession Number: 0001437749-19-002620
Submitted to the SEC: Thu Feb 14 2019 3:33:28 PM EST
Accepted by the SEC: Thu Feb 14 2019
Period: Monday, December 31, 2018
Industry: Medical Laboratories
External Resources:
Stock Quote
Social Media
SEC.gov
Bookmark the Permalink: https://last10k.com/sec-filings/aghc/0001437749-19-002620.htm
SEC Filing Exhibit
PDF Download
Loading SEC Filing Exhibit...
Excel DownloadLoading SEC Filing Financial Summary...